Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Ifosfamide). Showing records 1 – 16 of 16 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Delahousse, Julia. De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité : From ifosfamide to geranyloxy-ifosfamide : pharmacomodulation to target and modulate immunity.

Degree: Docteur es, Pharmacotechnie et biopharmacie, 2019, Université Paris-Saclay (ComUE)

L’ifosfamide (IFO) est un alkylant de l’ADN de la famille des Oxazaphosphorines, largement utilisé dans divers protocoles de chimiothérapie. Son utilisation en clinique est néanmoins… (more)

Subjects/Keywords: Ifosfamide; Géranyloxy-Ifosfamide; Pharmacomodulation; Immunomodulation; Ifosfamide; Geranyloxy-Ifosfamide; Pharmacomodulation; Immunomodulation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Delahousse, J. (2019). De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité : From ifosfamide to geranyloxy-ifosfamide : pharmacomodulation to target and modulate immunity. (Doctoral Dissertation). Université Paris-Saclay (ComUE). Retrieved from http://www.theses.fr/2019SACLS535

Chicago Manual of Style (16th Edition):

Delahousse, Julia. “De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité : From ifosfamide to geranyloxy-ifosfamide : pharmacomodulation to target and modulate immunity.” 2019. Doctoral Dissertation, Université Paris-Saclay (ComUE). Accessed January 18, 2021. http://www.theses.fr/2019SACLS535.

MLA Handbook (7th Edition):

Delahousse, Julia. “De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité : From ifosfamide to geranyloxy-ifosfamide : pharmacomodulation to target and modulate immunity.” 2019. Web. 18 Jan 2021.

Vancouver:

Delahousse J. De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité : From ifosfamide to geranyloxy-ifosfamide : pharmacomodulation to target and modulate immunity. [Internet] [Doctoral dissertation]. Université Paris-Saclay (ComUE); 2019. [cited 2021 Jan 18]. Available from: http://www.theses.fr/2019SACLS535.

Council of Science Editors:

Delahousse J. De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité : From ifosfamide to geranyloxy-ifosfamide : pharmacomodulation to target and modulate immunity. [Doctoral Dissertation]. Université Paris-Saclay (ComUE); 2019. Available from: http://www.theses.fr/2019SACLS535

2. LÃvia Talita Cajaseiras MourÃo. Envolvimento de Ãxido nÃtrico e de canais de potÃssio dependentes de ATP no efeito protetor da amifostina sobre as alteraÃÃes motoras funcionais e inflamatÃrias da Cistite hemorrÃgica induzida por Ifosfamida.

Degree: Master, 2012, Universidade Federal do Ceará

 A cistite hemorrÃgica (CH) Ã um evento inflamatÃrio frequentemente associado ao uso das oxazafosforinas. NÃs demonstramos que amifostina (AMF) pode prevenir o dano tecidual provocado… (more)

Subjects/Keywords: FARMACOLOGIA; Cistite; Ifosfamida; Amifostina; Cystitis; Ifosfamide; Amifostine; Bladder disfunction

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

MourÃo, L. T. C. (2012). Envolvimento de Ãxido nÃtrico e de canais de potÃssio dependentes de ATP no efeito protetor da amifostina sobre as alteraÃÃes motoras funcionais e inflamatÃrias da Cistite hemorrÃgica induzida por Ifosfamida. (Masters Thesis). Universidade Federal do Ceará. Retrieved from http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11958 ;

Chicago Manual of Style (16th Edition):

MourÃo, LÃvia Talita Cajaseiras. “Envolvimento de Ãxido nÃtrico e de canais de potÃssio dependentes de ATP no efeito protetor da amifostina sobre as alteraÃÃes motoras funcionais e inflamatÃrias da Cistite hemorrÃgica induzida por Ifosfamida.” 2012. Masters Thesis, Universidade Federal do Ceará. Accessed January 18, 2021. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11958 ;.

MLA Handbook (7th Edition):

MourÃo, LÃvia Talita Cajaseiras. “Envolvimento de Ãxido nÃtrico e de canais de potÃssio dependentes de ATP no efeito protetor da amifostina sobre as alteraÃÃes motoras funcionais e inflamatÃrias da Cistite hemorrÃgica induzida por Ifosfamida.” 2012. Web. 18 Jan 2021.

Vancouver:

MourÃo LTC. Envolvimento de Ãxido nÃtrico e de canais de potÃssio dependentes de ATP no efeito protetor da amifostina sobre as alteraÃÃes motoras funcionais e inflamatÃrias da Cistite hemorrÃgica induzida por Ifosfamida. [Internet] [Masters thesis]. Universidade Federal do Ceará 2012. [cited 2021 Jan 18]. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11958 ;.

Council of Science Editors:

MourÃo LTC. Envolvimento de Ãxido nÃtrico e de canais de potÃssio dependentes de ATP no efeito protetor da amifostina sobre as alteraÃÃes motoras funcionais e inflamatÃrias da Cistite hemorrÃgica induzida por Ifosfamida. [Masters Thesis]. Universidade Federal do Ceará 2012. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11958 ;

3. Pandit, Ambrish A. Solid Lipid Nanoparticulate Formulation for ifosfamide: Development and Characterization.

Degree: M.S. in Pharmaceutical Sciences, Pharmaceutical Science (graduate program), 2011, Creighton University

 The present research focuses on the development and characterization of a delivery system for ifosfamide to enhance its stability and sustaining in vitro release. Solid… (more)

Subjects/Keywords: Ifosfamide – chemistry; Nanoparticles – chemistry; Lipids – chemistry; Drug Delivery Systems

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pandit, A. A. (2011). Solid Lipid Nanoparticulate Formulation for ifosfamide: Development and Characterization. (Masters Thesis). Creighton University. Retrieved from http://hdl.handle.net/10504/16706

Chicago Manual of Style (16th Edition):

Pandit, Ambrish A. “Solid Lipid Nanoparticulate Formulation for ifosfamide: Development and Characterization.” 2011. Masters Thesis, Creighton University. Accessed January 18, 2021. http://hdl.handle.net/10504/16706.

MLA Handbook (7th Edition):

Pandit, Ambrish A. “Solid Lipid Nanoparticulate Formulation for ifosfamide: Development and Characterization.” 2011. Web. 18 Jan 2021.

Vancouver:

Pandit AA. Solid Lipid Nanoparticulate Formulation for ifosfamide: Development and Characterization. [Internet] [Masters thesis]. Creighton University; 2011. [cited 2021 Jan 18]. Available from: http://hdl.handle.net/10504/16706.

Council of Science Editors:

Pandit AA. Solid Lipid Nanoparticulate Formulation for ifosfamide: Development and Characterization. [Masters Thesis]. Creighton University; 2011. Available from: http://hdl.handle.net/10504/16706

4. Francisco Yuri BulÃÃo de MacÃdo. Efeito protetor da interleucina- 4 na cistite hemorrÃgica induzida por ifosfamida em camundongos.

Degree: Master, 2010, Universidade Federal do Ceará

A cistite hemorrÃgica (CH) Ã um efeito indesejado limitante do uso clÃnico dos agentes quimioterÃpicos do grupo das oxazafosforinas, principalmente ciclofosfamida (CFS) e ifosfamida (IFS).… (more)

Subjects/Keywords: FARMACOLOGIA; Cistite HemorrÃgica; Ifosfamida; Interleucina- 4; Hemorrhagic Cystitis; Ifosfamide; Interleukin- 4

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

MacÃdo, F. Y. B. d. (2010). Efeito protetor da interleucina- 4 na cistite hemorrÃgica induzida por ifosfamida em camundongos. (Masters Thesis). Universidade Federal do Ceará. Retrieved from http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=5159 ;

Chicago Manual of Style (16th Edition):

MacÃdo, Francisco Yuri BulÃÃo de. “Efeito protetor da interleucina- 4 na cistite hemorrÃgica induzida por ifosfamida em camundongos.” 2010. Masters Thesis, Universidade Federal do Ceará. Accessed January 18, 2021. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=5159 ;.

MLA Handbook (7th Edition):

MacÃdo, Francisco Yuri BulÃÃo de. “Efeito protetor da interleucina- 4 na cistite hemorrÃgica induzida por ifosfamida em camundongos.” 2010. Web. 18 Jan 2021.

Vancouver:

MacÃdo FYBd. Efeito protetor da interleucina- 4 na cistite hemorrÃgica induzida por ifosfamida em camundongos. [Internet] [Masters thesis]. Universidade Federal do Ceará 2010. [cited 2021 Jan 18]. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=5159 ;.

Council of Science Editors:

MacÃdo FYBd. Efeito protetor da interleucina- 4 na cistite hemorrÃgica induzida por ifosfamida em camundongos. [Masters Thesis]. Universidade Federal do Ceará 2010. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=5159 ;

5. Knouzy, Burhan. Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux : Chloroacetaldehyde : from the implication in the pathophysiological mechanisms of ifosfamide-induced nephrotoxicity to the contribution to its anticancerous effect.

Degree: Docteur es, Physiopathologie, 2009, Université Claude Bernard – Lyon I

Le chloroacétaldéhyde (CAA), un des principaux produits du métabolisme hépatique de l’ifosfamide (IFO), est considéré comme responsable de la néphrotoxicité de ce médicament. Les mécanismes… (more)

Subjects/Keywords: Ifosfamide; Chloroacétaldéhyde; Néphrotoxicité; Tranches; Cancer; MCF-7; Prolifération cellulaire; Glycolyse; Néoglucogenèse; Ifosfamide; Chloroacetaldehyde; Nephrotoxicity; Precision-cut slices; Cancer; MCF-7; Cell proliferation; Glycolysis; Gluconeogenesis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Knouzy, B. (2009). Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux : Chloroacetaldehyde : from the implication in the pathophysiological mechanisms of ifosfamide-induced nephrotoxicity to the contribution to its anticancerous effect. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2009LYO10209

Chicago Manual of Style (16th Edition):

Knouzy, Burhan. “Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux : Chloroacetaldehyde : from the implication in the pathophysiological mechanisms of ifosfamide-induced nephrotoxicity to the contribution to its anticancerous effect.” 2009. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed January 18, 2021. http://www.theses.fr/2009LYO10209.

MLA Handbook (7th Edition):

Knouzy, Burhan. “Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux : Chloroacetaldehyde : from the implication in the pathophysiological mechanisms of ifosfamide-induced nephrotoxicity to the contribution to its anticancerous effect.” 2009. Web. 18 Jan 2021.

Vancouver:

Knouzy B. Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux : Chloroacetaldehyde : from the implication in the pathophysiological mechanisms of ifosfamide-induced nephrotoxicity to the contribution to its anticancerous effect. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2009. [cited 2021 Jan 18]. Available from: http://www.theses.fr/2009LYO10209.

Council of Science Editors:

Knouzy B. Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux : Chloroacetaldehyde : from the implication in the pathophysiological mechanisms of ifosfamide-induced nephrotoxicity to the contribution to its anticancerous effect. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2009. Available from: http://www.theses.fr/2009LYO10209

6. Caio Abner Vitorino GonÃalves Leite. Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrÃgica induzida por ifosfamida.

Degree: Master, 2014, Universidade Federal do Ceará

Cistite hemorrÃgica (CH) induzida por ifosfamida (IFO) Ã uma importante complicaÃÃo clÃnica em pacientes com cÃncer. Atualmente, mesna e hiper- hidrataÃÃo sÃo utilizadas como profilaxia,… (more)

Subjects/Keywords: FARMACOLOGIA; Cistite; Ifosfamida; ProteÃna Antagonista do Receptor de Interleucina 1; Infliximab; Cystitis; Ifosfamide; Interleukin 1 Receptor Antagonist Protein; Infliximab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leite, C. A. V. G. (2014). Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrÃgica induzida por ifosfamida. (Masters Thesis). Universidade Federal do Ceará. Retrieved from http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=16492 ;

Chicago Manual of Style (16th Edition):

Leite, Caio Abner Vitorino GonÃalves. “Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrÃgica induzida por ifosfamida.” 2014. Masters Thesis, Universidade Federal do Ceará. Accessed January 18, 2021. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=16492 ;.

MLA Handbook (7th Edition):

Leite, Caio Abner Vitorino GonÃalves. “Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrÃgica induzida por ifosfamida.” 2014. Web. 18 Jan 2021.

Vancouver:

Leite CAVG. Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrÃgica induzida por ifosfamida. [Internet] [Masters thesis]. Universidade Federal do Ceará 2014. [cited 2021 Jan 18]. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=16492 ;.

Council of Science Editors:

Leite CAVG. Bloqueio do receptor da interleucina-1 com Anakinra Inibe a cistite hemorrÃgica induzida por ifosfamida. [Masters Thesis]. Universidade Federal do Ceará 2014. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=16492 ;

7. Rocha, Otávio Pelegrino. Disposição cinética dos enantiômeros da ifosfamida em pacientes portadoras de câncer de colo do útero.

Degree: Mestrado, Toxicologia, 2013, University of São Paulo

A ifosfamida é um pró-fármaco que apresenta um átomo de fósforo quiral, disponível na clínica como mistura racêmica dos enantiômeros(+)-(R)-ifosfamida e (-)-(S)-ifosfamida para a utilização… (more)

Subjects/Keywords: câncer de colo do útero; Cervical cancer; enantiomer; enantiômero; farmacocinética; ifosfamida; ifosfamide; LC-MS/MS; LCMS/ MS; pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rocha, O. P. (2013). Disposição cinética dos enantiômeros da ifosfamida em pacientes portadoras de câncer de colo do útero. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/60/60134/tde-26062013-092507/ ;

Chicago Manual of Style (16th Edition):

Rocha, Otávio Pelegrino. “Disposição cinética dos enantiômeros da ifosfamida em pacientes portadoras de câncer de colo do útero.” 2013. Masters Thesis, University of São Paulo. Accessed January 18, 2021. http://www.teses.usp.br/teses/disponiveis/60/60134/tde-26062013-092507/ ;.

MLA Handbook (7th Edition):

Rocha, Otávio Pelegrino. “Disposição cinética dos enantiômeros da ifosfamida em pacientes portadoras de câncer de colo do útero.” 2013. Web. 18 Jan 2021.

Vancouver:

Rocha OP. Disposição cinética dos enantiômeros da ifosfamida em pacientes portadoras de câncer de colo do útero. [Internet] [Masters thesis]. University of São Paulo; 2013. [cited 2021 Jan 18]. Available from: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-26062013-092507/ ;.

Council of Science Editors:

Rocha OP. Disposição cinética dos enantiômeros da ifosfamida em pacientes portadoras de câncer de colo do útero. [Masters Thesis]. University of São Paulo; 2013. Available from: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-26062013-092507/ ;

8. Çengelli, Çiğdem. Serebellar granül hücreleri üzerine sisplatin ve ifosfamid nörotoksisitesinde Ca+2 ve katp kanallarının rolü .

Degree: ESOGÜ, Tıp Fakültesi, Tıbbi Farmakoloji, 2013, Eskisehir Osmangazi University

 Sisplatin veya ifosfamid gibi antineoplastiklerin neden olduğu nörotoksisite glutamata-bağlı eksitotoksik özelliklere sahiptir. Eksitotoksisitede ise hücre içine kalsiyum girişinin toksisiteyi arttırdığı ancak potasyum çıkışının toksisiteyi azalttığı… (more)

Subjects/Keywords: İfosfamid; Kalsiyum; KATP Kanalları; Nörotoksisite; Serebellar Granül Hücreleri; Sisplatin; Calcium; Cerebellar Granule Cells; Cisplatin; Ifosfamide; KATP Channels; Neurotoxicity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Çengelli, . (2013). Serebellar granül hücreleri üzerine sisplatin ve ifosfamid nörotoksisitesinde Ca+2 ve katp kanallarının rolü . (Thesis). Eskisehir Osmangazi University. Retrieved from http://hdl.handle.net/11684/722

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Çengelli, Çiğdem. “Serebellar granül hücreleri üzerine sisplatin ve ifosfamid nörotoksisitesinde Ca+2 ve katp kanallarının rolü .” 2013. Thesis, Eskisehir Osmangazi University. Accessed January 18, 2021. http://hdl.handle.net/11684/722.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Çengelli, Çiğdem. “Serebellar granül hücreleri üzerine sisplatin ve ifosfamid nörotoksisitesinde Ca+2 ve katp kanallarının rolü .” 2013. Web. 18 Jan 2021.

Vancouver:

Çengelli . Serebellar granül hücreleri üzerine sisplatin ve ifosfamid nörotoksisitesinde Ca+2 ve katp kanallarının rolü . [Internet] [Thesis]. Eskisehir Osmangazi University; 2013. [cited 2021 Jan 18]. Available from: http://hdl.handle.net/11684/722.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Çengelli . Serebellar granül hücreleri üzerine sisplatin ve ifosfamid nörotoksisitesinde Ca+2 ve katp kanallarının rolü . [Thesis]. Eskisehir Osmangazi University; 2013. Available from: http://hdl.handle.net/11684/722

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Freie Universität Berlin

9. Kurreck, Annika. Cisplatin plus Ifosfamide with/without Etoposide as salvage treatment in heavily pretreated patients with metastatic breast bancer.

Degree: 2016, Freie Universität Berlin

 Background: Breast cancer is the most common cancer in women worldwide representing approximately 25% of all malignant tumors in females. Despite new treatment options and… (more)

Subjects/Keywords: Metastatic breast cancer; chemotherapy; platinum; etoposide; ifosfamide; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kurreck, A. (2016). Cisplatin plus Ifosfamide with/without Etoposide as salvage treatment in heavily pretreated patients with metastatic breast bancer. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-11051

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kurreck, Annika. “Cisplatin plus Ifosfamide with/without Etoposide as salvage treatment in heavily pretreated patients with metastatic breast bancer.” 2016. Thesis, Freie Universität Berlin. Accessed January 18, 2021. http://dx.doi.org/10.17169/refubium-11051.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kurreck, Annika. “Cisplatin plus Ifosfamide with/without Etoposide as salvage treatment in heavily pretreated patients with metastatic breast bancer.” 2016. Web. 18 Jan 2021.

Vancouver:

Kurreck A. Cisplatin plus Ifosfamide with/without Etoposide as salvage treatment in heavily pretreated patients with metastatic breast bancer. [Internet] [Thesis]. Freie Universität Berlin; 2016. [cited 2021 Jan 18]. Available from: http://dx.doi.org/10.17169/refubium-11051.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kurreck A. Cisplatin plus Ifosfamide with/without Etoposide as salvage treatment in heavily pretreated patients with metastatic breast bancer. [Thesis]. Freie Universität Berlin; 2016. Available from: http://dx.doi.org/10.17169/refubium-11051

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. ZHANG JING. Role of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the resistance and toxicity of oxazaphosphorines.

Degree: 2009, National University of Singapore

Subjects/Keywords: cyclophosphamide; ifosfamide; multidrug-associated protein 4(MRP4/ABCC4)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

JING, Z. (2009). Role of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the resistance and toxicity of oxazaphosphorines. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/16338

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

JING, ZHANG. “Role of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the resistance and toxicity of oxazaphosphorines.” 2009. Thesis, National University of Singapore. Accessed January 18, 2021. http://scholarbank.nus.edu.sg/handle/10635/16338.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

JING, ZHANG. “Role of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the resistance and toxicity of oxazaphosphorines.” 2009. Web. 18 Jan 2021.

Vancouver:

JING Z. Role of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the resistance and toxicity of oxazaphosphorines. [Internet] [Thesis]. National University of Singapore; 2009. [cited 2021 Jan 18]. Available from: http://scholarbank.nus.edu.sg/handle/10635/16338.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

JING Z. Role of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the resistance and toxicity of oxazaphosphorines. [Thesis]. National University of Singapore; 2009. Available from: http://scholarbank.nus.edu.sg/handle/10635/16338

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Almeida, Gustavo Fernandes Godoy. Doxorrubicina e ifosfamida em dose densa em pacientes com sarcomas de partes moles e expressão de ezrina como fator de prognóstico.

Degree: PhD, Oncologia, 2010, University of São Paulo

 O prognóstico de pacientes portadores de sarcomas de partes moles (SPM) avançados é reservado. Aumentar o benefício de quimioterapia é necessário, sendo, uma das estratégias,… (more)

Subjects/Keywords: Dose-response relationship drug; Doxorrubicina; Doxorubicin; Ifosfamida; Ifosfamide; Immunohistochemistry; Imunoistoquímica; Relação dose-resposta a droga; Sarcoma; Sarcoma de partesmoles; Sobrevida; Survivorship (Public Health)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Almeida, G. F. G. (2010). Doxorrubicina e ifosfamida em dose densa em pacientes com sarcomas de partes moles e expressão de ezrina como fator de prognóstico. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/5/5155/tde-08062010-160840/ ;

Chicago Manual of Style (16th Edition):

Almeida, Gustavo Fernandes Godoy. “Doxorrubicina e ifosfamida em dose densa em pacientes com sarcomas de partes moles e expressão de ezrina como fator de prognóstico.” 2010. Doctoral Dissertation, University of São Paulo. Accessed January 18, 2021. http://www.teses.usp.br/teses/disponiveis/5/5155/tde-08062010-160840/ ;.

MLA Handbook (7th Edition):

Almeida, Gustavo Fernandes Godoy. “Doxorrubicina e ifosfamida em dose densa em pacientes com sarcomas de partes moles e expressão de ezrina como fator de prognóstico.” 2010. Web. 18 Jan 2021.

Vancouver:

Almeida GFG. Doxorrubicina e ifosfamida em dose densa em pacientes com sarcomas de partes moles e expressão de ezrina como fator de prognóstico. [Internet] [Doctoral dissertation]. University of São Paulo; 2010. [cited 2021 Jan 18]. Available from: http://www.teses.usp.br/teses/disponiveis/5/5155/tde-08062010-160840/ ;.

Council of Science Editors:

Almeida GFG. Doxorrubicina e ifosfamida em dose densa em pacientes com sarcomas de partes moles e expressão de ezrina como fator de prognóstico. [Doctoral Dissertation]. University of São Paulo; 2010. Available from: http://www.teses.usp.br/teses/disponiveis/5/5155/tde-08062010-160840/ ;

12. Calinski, Diane M. Oxazaphosphorine Metabolism by the Human Cytochrome P450s and Some Commonly Expressed P450 Polymorphic Variants.

Degree: PhD, Pharmacology, 2013, University of Michigan

 The oxazaphosphorines, cyclophosphamide (CPA) and ifosfamide (IFO), are commonly used cancer therapeutics. Hallmarks of oxazaphosphorine-treatment include variable patient response and severe adverse drug reactions. These… (more)

Subjects/Keywords: P450; Polymorphic Variants; Cyclophosphamide; Ifosfamide; Pharmacy and Pharmacology; Health Sciences

…OF IFOSFAMIDE AND DEUTERATED IFOSFAMIDE BY THE CYTOCHROME P450S AND THEIR COMMON… …Oxazaphosphorines 14 1.6 Cyclophosphamide Metabolism 15 1.7 Ifosfamide Metabolism 19 2.1 Steady… …Inhibitors cyclophosphamide phenobarbital thiotepa ifosfamide clopidogrel efavirenz… …agents cyclophosphamide and ifosfamide are prodrugs and require activation by CYP2B6 to have a… …top structure is cyclophosphamide and the bottom is ifosfamide. Ifosfamide and… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Calinski, D. M. (2013). Oxazaphosphorine Metabolism by the Human Cytochrome P450s and Some Commonly Expressed P450 Polymorphic Variants. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/99932

Chicago Manual of Style (16th Edition):

Calinski, Diane M. “Oxazaphosphorine Metabolism by the Human Cytochrome P450s and Some Commonly Expressed P450 Polymorphic Variants.” 2013. Doctoral Dissertation, University of Michigan. Accessed January 18, 2021. http://hdl.handle.net/2027.42/99932.

MLA Handbook (7th Edition):

Calinski, Diane M. “Oxazaphosphorine Metabolism by the Human Cytochrome P450s and Some Commonly Expressed P450 Polymorphic Variants.” 2013. Web. 18 Jan 2021.

Vancouver:

Calinski DM. Oxazaphosphorine Metabolism by the Human Cytochrome P450s and Some Commonly Expressed P450 Polymorphic Variants. [Internet] [Doctoral dissertation]. University of Michigan; 2013. [cited 2021 Jan 18]. Available from: http://hdl.handle.net/2027.42/99932.

Council of Science Editors:

Calinski DM. Oxazaphosphorine Metabolism by the Human Cytochrome P450s and Some Commonly Expressed P450 Polymorphic Variants. [Doctoral Dissertation]. University of Michigan; 2013. Available from: http://hdl.handle.net/2027.42/99932

13. Hanly, Lauren. N-acetylcysteine as a chemoprotectant against ifosfamide nephrotoxicity; from mechanism to prevention.

Degree: 2013, University of Western Ontario

 The chemotherapy drug ifosfamide is used in the treatment of several childhood cancers. While effective, its use in children results in a 30% incidence of… (more)

Subjects/Keywords: ifosfamide; nephrotoxicity; n-acetylcysteine; pharmacokinetics; antitumour efficacy; translational research; Pharmacology

…2 1.2 Ifosfamide Metabolism ... ….3 1.2.1. Qualitative difference in… …ifosfamide versus cyclophosphamide metabolism ... ..8 1.2.2 Chloroacetaldehyde… …8 1.3 Ifosfamide-induced nephrotoxicity .... .9 1.3.1 Clinical… …presentation of ifosfamide-induced nephrotoxicity …..10 1.3.2 Fanconi syndrome… …treatment ….. …... ..14 1.3.5 Ifosfamide-induced nephrotoxicity at a cellular level… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hanly, L. (2013). N-acetylcysteine as a chemoprotectant against ifosfamide nephrotoxicity; from mechanism to prevention. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/1483

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hanly, Lauren. “N-acetylcysteine as a chemoprotectant against ifosfamide nephrotoxicity; from mechanism to prevention.” 2013. Thesis, University of Western Ontario. Accessed January 18, 2021. https://ir.lib.uwo.ca/etd/1483.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hanly, Lauren. “N-acetylcysteine as a chemoprotectant against ifosfamide nephrotoxicity; from mechanism to prevention.” 2013. Web. 18 Jan 2021.

Vancouver:

Hanly L. N-acetylcysteine as a chemoprotectant against ifosfamide nephrotoxicity; from mechanism to prevention. [Internet] [Thesis]. University of Western Ontario; 2013. [cited 2021 Jan 18]. Available from: https://ir.lib.uwo.ca/etd/1483.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hanly L. N-acetylcysteine as a chemoprotectant against ifosfamide nephrotoxicity; from mechanism to prevention. [Thesis]. University of Western Ontario; 2013. Available from: https://ir.lib.uwo.ca/etd/1483

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. Ζώρζου, Μαρκέλα-Παγωνίτσα. Σαρκώματα γυναικείου γεννητικού συστήματος.

Degree: 2007, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens

 χημειοθεραπεία. Οι ασθενείς αυτοί θεωρήθηκαν υψηλού κινδύνου για υποτροπή με βάση ένα τουλάχιστον από τα παρακάτω ευρήματα: διάμετρο όγκου >= 5cm, στάδιο νόσου >=ΙΒ, βαθμός… (more)

Subjects/Keywords: Σάρκωμα; Καρκινοσάρκωμα; Λειομυοσάρκωμα; Ενδομητρικό στρωματικό σάρκωμα; Ανοσοϊστοχημεία; Προγνωστικοί παράγοντες; Ανθρακυκλίνη; Ιφωσφαμίδη; Ulterine sarcomas; Carcinosarcoma; Leiomyosarcoma; Stromal sarcoma; Immunochemistry; Prognostic factors; Anthracyclines; Ifosfamide

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ζώρζου, . (2007). Σαρκώματα γυναικείου γεννητικού συστήματος. (Thesis). Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens. Retrieved from http://hdl.handle.net/10442/hedi/18378

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ζώρζου, Μαρκέλα-Παγωνίτσα. “Σαρκώματα γυναικείου γεννητικού συστήματος.” 2007. Thesis, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens. Accessed January 18, 2021. http://hdl.handle.net/10442/hedi/18378.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ζώρζου, Μαρκέλα-Παγωνίτσα. “Σαρκώματα γυναικείου γεννητικού συστήματος.” 2007. Web. 18 Jan 2021.

Vancouver:

Ζώρζου . Σαρκώματα γυναικείου γεννητικού συστήματος. [Internet] [Thesis]. Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens; 2007. [cited 2021 Jan 18]. Available from: http://hdl.handle.net/10442/hedi/18378.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ζώρζου . Σαρκώματα γυναικείου γεννητικού συστήματος. [Thesis]. Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens; 2007. Available from: http://hdl.handle.net/10442/hedi/18378

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Lund

15. Hedmer, Maria. Monitoring of occupational exposure to antineoplastic drugs.

Degree: 2006, University of Lund

 Antineoplastic drugs are commonly used in the medical treatment of cancer and some other diseases. Workplaces e.g. hospital pharmacies and wards where antineoplastic drugs are… (more)

Subjects/Keywords: Environmental Health and Occupational Health; industrial medicine; Occupational health; plasma; urine; renal clearance; risk evaluation; biological monitoring; air monitoring; wipe sampling; occupational exposure; ifosfamide; antineoplastic drugs; cyclophosphamide; Yrkesmedicin; arbetsmiljömedicin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hedmer, M. (2006). Monitoring of occupational exposure to antineoplastic drugs. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/546643 ; https://portal.research.lu.se/ws/files/4525228/546645.pdf

Chicago Manual of Style (16th Edition):

Hedmer, Maria. “Monitoring of occupational exposure to antineoplastic drugs.” 2006. Doctoral Dissertation, University of Lund. Accessed January 18, 2021. https://lup.lub.lu.se/record/546643 ; https://portal.research.lu.se/ws/files/4525228/546645.pdf.

MLA Handbook (7th Edition):

Hedmer, Maria. “Monitoring of occupational exposure to antineoplastic drugs.” 2006. Web. 18 Jan 2021.

Vancouver:

Hedmer M. Monitoring of occupational exposure to antineoplastic drugs. [Internet] [Doctoral dissertation]. University of Lund; 2006. [cited 2021 Jan 18]. Available from: https://lup.lub.lu.se/record/546643 ; https://portal.research.lu.se/ws/files/4525228/546645.pdf.

Council of Science Editors:

Hedmer M. Monitoring of occupational exposure to antineoplastic drugs. [Doctoral Dissertation]. University of Lund; 2006. Available from: https://lup.lub.lu.se/record/546643 ; https://portal.research.lu.se/ws/files/4525228/546645.pdf

16. Κυριακάκης, Ζαχαρίας. Συνδυασμός σισπλατίνης, ιφωσφαμίδης, μεθοτρεξάτης και βιμπλαστίνης στο μεταστατικό καρκίνο των ουροφόρων οδών.

Degree: 1997, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens

ΣΚΟΠΟΣ ΤΗΣ ΕΡΓΑΣΙΑΣ ΗΤΑΝ Η ΜΕΛΕΤΗ ΤΗΣ ΑΠΟΤΕΛΕΣΜΑΤΙΚΟΤΗΤΑΣ ΚΑΙ ΤΟΞΙΤΟΤΗΤΑΣ ΤΟΥ ΧΗΜΕΙΟΘΕΡΑΠΕΥΤΙΚΟΥ ΣΥΝΔΥΑΣΜΟΥ ΣΙΣΠΛΑΤΙΝΗΣ,ΙΦΩΣΦΑΜΙΔΗΣ, ΜΕΘΟΤΡΕΞΑΤΗΣ ΚΑΙ ΒΙΝΜΠΛΑΣΤΙΝΗΣ ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΜΕΤΑΣΤΑΤΙΚΟ ΚΑΡΚΙΝΟ ΤΟΥ ΟΥΡΟΘΗΛΙΟΥ.Η ΚΥΡΙΩΤΕΡΗ… (more)

Subjects/Keywords: Χημειοθεραπεία; Χημειοθεραπεία συστηματική; Καρκίνος μεταστατικός; Ουροθήλιο; Σισπλατίνη; Ιφωσφαμίδη; Μεθοτρεξάτη; Βινβλαστίνη; Βιμπλαστίνη; Καρκίνος ουροδόχου κύστης; Καρκίνος ουροδόχου κύστης; Chemotherapy; Chemotherapy systematic; Metastatic cancer; Urothelium; Cis platin (Cis - dichloro - diamino - platinum); Ifosfamide; Methotrexate; Viblastine; Vinblastine; Urinary bladder carcinoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Κυριακάκης, . (1997). Συνδυασμός σισπλατίνης, ιφωσφαμίδης, μεθοτρεξάτης και βιμπλαστίνης στο μεταστατικό καρκίνο των ουροφόρων οδών. (Thesis). Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens. Retrieved from http://hdl.handle.net/10442/hedi/12158

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Κυριακάκης, Ζαχαρίας. “Συνδυασμός σισπλατίνης, ιφωσφαμίδης, μεθοτρεξάτης και βιμπλαστίνης στο μεταστατικό καρκίνο των ουροφόρων οδών.” 1997. Thesis, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens. Accessed January 18, 2021. http://hdl.handle.net/10442/hedi/12158.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Κυριακάκης, Ζαχαρίας. “Συνδυασμός σισπλατίνης, ιφωσφαμίδης, μεθοτρεξάτης και βιμπλαστίνης στο μεταστατικό καρκίνο των ουροφόρων οδών.” 1997. Web. 18 Jan 2021.

Vancouver:

Κυριακάκης . Συνδυασμός σισπλατίνης, ιφωσφαμίδης, μεθοτρεξάτης και βιμπλαστίνης στο μεταστατικό καρκίνο των ουροφόρων οδών. [Internet] [Thesis]. Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens; 1997. [cited 2021 Jan 18]. Available from: http://hdl.handle.net/10442/hedi/12158.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Κυριακάκης . Συνδυασμός σισπλατίνης, ιφωσφαμίδης, μεθοτρεξάτης και βιμπλαστίνης στο μεταστατικό καρκίνο των ουροφόρων οδών. [Thesis]. Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); National and Kapodistrian University of Athens; 1997. Available from: http://hdl.handle.net/10442/hedi/12158

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.